AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: Monika Tjia
After breaking out of a four-month base on April 25, Diagnostic Products gained 47% in six weeks. Since then it has formed a 13-week base, and now sits 2% off its high.
Its Relative Strength line is at a new high, a bullish sign.
The Los Angeles-based firm makes tests to diagnose ailments ranging from diabetes to allergies. It's the largest independent immunoassay test maker, which reveals the presence or absence of an antigen or antibody.
Profit growth has ranged from 25% to 36% in the past six quarters. Analysts predict fiscal 2001 earnings will increase 26% vs. a 33% rise in 2000, says First Call.
Sales growth has been in the double digits during the same period, ranging from 12% to 17%.
Sponsorship has picked up in ...